Wednesday, December 13, 2017

Federal Food, Drug, and Cosmetic Act Amendment Signed Into Law

By Greg Walden (R-OR, 2nd)



Washington, D.C. - December 13, 2017 - (The Ponder News) -- President Trump signed into law legislation introduced by Rep. Greg Walden (R-Hood River) to ensure the military has access to lifesaving medical treatments. Walden’s legislation (H.R. 4374) passed the House and Senate unanimously, and will amend the Federal Food, Drug, and Cosmetic Act to authorize additional emergency uses for medical products to reduce deaths and severity of injuries caused by agents of war.

“This is an important day for our brave men and women in uniform, ensuring they get the timely care they need while protecting our country,” said Walden. “Today we are well on our way to delivering the newest treatments and devices to our war fighters without forgoing important safety mechanisms.”

Specifically, Walden’s legislation corrects language within the National Defense Authorization Act – which was also signed into law today – that could have usurped FDA’s critical authority of ensuring the safety and efficacy of cutting edge medicines for our soldiers on the front lines.

Walden’s bill will streamline the processes at the Food and Drug Administration (FDA) and Department of Defense (DoD) to ensure America’s warfighters have access to new, lifesaving medications in a timely manner.

''Our men and women in uniform put their lives on the line for this country, and they deserve to have the earliest possible access to medical products that could save their lives on the battlefield,” said Walden in a speech on the House floor when the legislation passed the House in November. “In short, H.R. 4374 addresses the critical issue of military access to the newest available products by expanding the circumstances under which emergency use authorizations can be issued, and by establishing an expedited pathway to full approval of products that the Secretary of Defense requests.”

For Representative Walden’s legislation, please click here.


No comments:

Post a Comment